Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dideu Industries Group is a major Chinese chemical and pharmaceutical enterprise that produces and sells active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and chemical raw materials. The company is especially known as a supplier of anti-tumor drugs, surgical medications, and diagnostic contrast agents, with a significant footprint in China and exports to over 20 countries. The company operates at a commercial scale with an ongoing R&D investment (>15% of sales), including activity as the lead unit of national targeted drug technology innovation alliances and drug engineering research centers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dideu Industries Group.